NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
84 hedge funds and large institutions have $667M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 32 increasing their positions, 18 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
+11
Holders Change %
+15.07%
% of All Funds
1.73%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
21
Increased
32
Reduced
18
Closed
10
Calls
$13K
Puts
–
Net Calls
+$13K
Net Calls Change
+$13K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
$27.8M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
$30.1M |
| 3 |
PS
Peter Svennilson
|
$350M |
| 4 |
Morgan Stanley
New York
|
$3.66M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
$1.6M |
